Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
18.4 µM
Hemolytic
Cytotoxic
50% Hemolysis | 18.4 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Analogues of peptide SMAP-29 with comparable antimicrobial potency and reduced cytotoxicity. | Int J Antimicrob Agents | 2011